Clinical overview
Cervical intraepithelial neoplasia (CIN) is the squamous precursor of cervical cancer — a spectrum of dysplastic change confined to the cervical epithelium, lying above an intact basement membrane. It matters enormously to a South African registrar because cervical cancer remains the leading cause of cancer death in women in South Africa, driven by a generalised HIV epidemic that accelerates the entire HPV → CIN → cancer pathway. The whole logic of screening, vaccination and treat-and-prevent programmes rests on a single biological fact: there is a long, interruptible precancerous phase. Understanding CIN pathophysiology is understanding why that window exists, why HIV narrows it, and why a thermal-ablation probe at a primary-care clinic can prevent an invasive cancer a decade later.
The key reframing to carry into the exam: CIN is not simply "early cancer". It is the morphological footprint of a productive-then-transforming human papillomavirus (HPV) infection. Most HPV infections — and most low-grade lesions — clear spontaneously through cell-mediated immunity. A minority persist, and within that minority the virus' oncogenes progressively dysregulate the cell cycle until a clone acquires the genomic instability that allows it to breach the basement membrane. CIN is the visible histological correlate of that biology, and the WHO 2020 / LAST terminology (LSIL/HSIL) was designed precisely to map morphology onto this two-tier biology — productive infection versus true precancer. This chapter focuses on mechanism; the practical screening and ablation/excision algorithms are developed in Cervical screening SA and CIN management, and the broader virology in HPV pathology and Cervical carcinogenesis.
Core knowledge
The transformation zone — where CIN happens
Figure D8.1 — The transformation zone and squamocolumnar junction: immature squamous metaplasia is the HPV-vulnerable field where CIN arises.
CIN does not arise randomly across the cervix; it arises almost exclusively in the transformation zone (TZ). The native ectocervix is covered by mature stratified squamous epithelium; the endocervical canal by a single layer of columnar (glandular) epithelium. The junction between them — the squamocolumnar junction (SCJ) — is not fixed. Under the influence of oestrogen, low vaginal pH (menarche, pregnancy, combined hormonal contraception), the original columnar epithelium that has everted onto the ectocervix undergoes squamous metaplasia, converting to squamous epithelium and shifting the functional SCJ inward over a woman's reproductive life.
This metaplastic transformation zone is the vulnerable site for two reasons. First, metaplasia proceeds via reserve cells — undifferentiated, mitotically active cells beneath the columnar layer — which are exactly the actively dividing basal-type cells HPV needs to infect and establish a persistent reservoir. Second, the SCJ harbours a discrete population of cuboidal junctional cells (an embryologically distinct residual population) that appear especially susceptible to HPV-driven transformation; almost all HPV-associated CIN3 and squamous carcinoma localise to this zone. The clinical corollary is that colposcopy is fundamentally an examination of the transformation zone, and that as the SCJ recedes into the canal with age, the TZ becomes less visible — making cytology and HPV testing (rather than visual inspection) the more reliable screen in older women. (See Colposcopy and Benign cervical pathology.)
HPV — the necessary cause
Cervical squamous neoplasia is, to a first approximation, an obligate consequence of persistent infection with high-risk (oncogenic) HPV genotypes. HPV is a small non-enveloped double-stranded DNA virus. Around 14 genotypes are oncogenic; HPV 16 and 18 account for roughly 70% of cervical cancers worldwide, with 16 the dominant driver of HSIL and squamous carcinoma and 18 over-represented in adenocarcinoma. Other high-risk types (31, 33, 45, 52, 58 and others) make up much of the remainder — the rationale for the broad coverage of the nonavalent (9-valent) vaccine endorsed in the WHO programme.
The virus reaches the basal/reserve cells through micro-abrasions in the metaplastic epithelium. There it can establish two distinct biological states, and the distinction is the conceptual spine of this whole topic:
- Productive (permissive) infection. The viral genome persists as a low-copy episome (free circular DNA, not integrated). As the infected basal cell divides and its progeny differentiate upward, the virus co-opts the differentiation programme to complete its life cycle — amplifying its genome and assembling new virions in the upper layers. The cytopathic signature of this is the koilocyte: a superficial squamous cell with a perinuclear halo, nuclear enlargement and irregularity, reflecting the action of the viral E4 protein on the cytokeratin cytoskeleton. Productive infection corresponds morphologically to LSIL / CIN1 and is the cervix doing what most infected cervices do — supporting a transient, immunologically self-limiting infection.